Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections
Изучение гликолитических ферментов при заболеваниях: потенциальные биомаркеры и терапевтические мишени при нейродегенеративных заболеваниях, раке и паразитарных инфекциях
2025-02-01
SCID: 54.1/6tbtyyys
Discuss with AI
cancerglycolytic enzymesneurodegenerationparasitic infectionstherapeutic targets
Figures from the paper
Abstract (AI)
Glycolysis, present in most organisms, is evolutionarily one of the oldest metabolic pathways. It has great relevance at a physiological level because it is responsible for generating ATP in the cell through the conversion of glucose into pyruvate and reducing nicotinamide adenine dinucleotide (NADH) (that may be fed into the electron chain in the mitochondria to produce additional ATP by oxidative phosphorylation), as well as for producing intermediates that can serve as substrates for other metabolic processes. Glycolysis takes place through 10 consecutive chemical reactions, each of which is catalysed by a specific enzyme. Although energy transduction by glucose metabolism is the main function of this pathway, involvement in virulence, growth, pathogen-host interactions, immunomodulation and adaptation to environmental conditions are other functions attributed to this metabolic pathway. In humans, where glycolysis occurs mainly in the cytosol, the mislocalization of some glycolytic enzymes in various other subcellular locations, as well as alterations in their expression and regulation, has been associated with the development and progression of various diseases. In this review, we describe the role of glycolytic enzymes in the pathogenesis of diseases of clinical interest. In addition, the potential role of these enzymes as targets for drug development and their potential for use as diagnostic and prognostic markers of some pathologies are also discussed.
Key Findings
1
Altered expression, regulation, or subcellular mislocalization of human glycolytic enzymes is associated with disease development and progression.
2
Beyond energy metabolism, glycolytic pathways contribute to virulence, pathogen–host interactions, immunomodulation, growth, and environmental adaptation.
3
Glycolysis supports ATP and NADH production while supplying metabolic intermediates for additional cellular processes.
4
Glycolytic enzymes are highlighted as potential therapeutic targets for drug development in neurodegeneration, cancer, and parasitic infections.
5
Glycolytic enzymes may serve as diagnostic and prognostic biomarkers for clinically relevant diseases.
Research Object
Glycolytic enzymes in human diseases and parasitic infections, particularly neurodegeneration, cancer, and pathogen–host interactions
Research Subject
The roles, dysregulation, and disease-associated localization of glycolytic enzymes, including their potential as therapeutic targets and diagnostic or prognostic biomarkers
Publication Details
Publication Date
2025-02-01
Journal
Publisher
ISSN
Cited by
32
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 20192022
Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)2012
Wnt signaling in colorectal cancer: pathogenic role and therapeutic target2022